Below is a list of breast cancer clinical trials run by the Breast Surgical Oncology department at MD Anderson. We have clinical trials for many different types of breast cancer including ductal carcinoma in situ (DCIS), HER2-positive, node-positive/HER-negative, lobular carcinoma, triple negative breast cancer and more.
Trial availability may change without notice. Individual trial spots may open or close without notice. Click on the study link for detailed information about each clinical trial.
Last updated 6/17/2020
Study: ALLIANCE A221702
Intervention: isosulfan blue, axillary lymph node dissection, mapping
NIH link: NCT03927027
Study: ALLIANCE A011202
Interventions: axillary lymph node dissection, radiation therapy
NIH link: NCT01901094
All Clinical Trials
MD Anderson patients have access to clinical trials offering research studies that cannot be found anywhere else.
Several other departments including Radiation Oncology, Investigational Cancer Therapeutics and Breast Medical Oncology also offer clinical trials that may be open to breast cancer patients.